Beijing Chunlizhengda Medical Instruments Co
Beijing Chunlizhengda Medical Instruments Co., Ltd., commonly referred to as Chunlizhengda, is a leading player in the medical device industry, headquartered in Beijing, China. Established in 2000, the company has made significant strides in the development and manufacturing of high-quality medical instruments, particularly in the fields of orthopaedics and minimally invasive surgery. Chunlizhengda's core product offerings include advanced surgical instruments and innovative medical solutions that cater to both domestic and international markets. Renowned for their precision and reliability, these products have positioned the company as a trusted name among healthcare professionals. With a commitment to research and development, Chunlizhengda continues to enhance its market presence, contributing to the advancement of medical technology and improving patient outcomes globally.
DitchCarbon Score
How does Beijing Chunlizhengda Medical Instruments Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Beijing Chunlizhengda Medical Instruments Co's score of 27 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Beijing Chunlizhengda Medical Instruments Co's reported carbon emissions
In 2022, Beijing Chunlizhengda Medical Instruments Co., Ltd. reported total carbon emissions of approximately 3,239,250 kg CO2e. This figure includes 19,370 kg CO2e from Scope 1 emissions, 3,216,900 kg CO2e from Scope 2 emissions, and 6,980 kg CO2e from Scope 3 emissions. The company's revenue for the same year was about USD 174 million. The company has set ambitious climate commitments, aiming for a 35% reduction in CO2 emissions intensity by 2030. This target is based on a decrease from 0.0243 tonnes of CO2 emissions per RMB 10,000 of products in 2020 to 0.0157% by 2030. This commitment applies to both Scope 1 and Scope 2 emissions, reflecting the company's strategic focus on sustainability in line with industry development characteristics. In 2021, the company reported total emissions of approximately 2,095,900 kg CO2e, with Scope 1 emissions at 10,910 kg CO2e and Scope 3 emissions at 3,990 kg CO2e. The data indicates a proactive approach to managing carbon emissions, although specific achievements in emissions reduction were not detailed. Overall, Beijing Chunlizhengda Medical Instruments Co. is positioning itself to significantly reduce its carbon footprint in the coming years, aligning with global climate action goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 10,910 | 00,000 |
| Scope 2 | 2,092,900 | 0,000,000 |
| Scope 3 | 3,990 | 0,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Beijing Chunlizhengda Medical Instruments Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
